Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
Clinical trial NCT05382078 · UNKNOWN
Trial details
- NCT number
- NCT05382078
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-31
- Primary completion
- 2023-05-04
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.